131 related articles for article (PubMed ID: 35069050)
1. Preparation of Liposomal Raloxifene-Graphene Nanosheet and Evaluation of Its
Altyar AE; Fahmy O
Dose Response; 2022; 20(1):15593258211063983. PubMed ID: 35069050
[TBL] [Abstract][Full Text] [Related]
2. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
Jain A; Sharma T; Kumar R; Katare OP; Singh B
Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
[TBL] [Abstract][Full Text] [Related]
3. Optimized semisolid self-nanoemulsifying system based on glyceryl behenate: A potential nanoplatform for enhancing antitumor activity of raloxifene hydrochloride in MCF-7 human breast cancer cells.
Badr-Eldin SM; Aldawsari HM; Ahmed OAA; Alhakamy NA; Neamatallah T; Okbazghi SZ; Fahmy UA
Int J Pharm; 2021 May; 600():120493. PubMed ID: 33744452
[TBL] [Abstract][Full Text] [Related]
4. Self-Assembling Raloxifene Loaded Mixed Micelles: Formulation Optimization, In Vitro Cytotoxicity and In Vivo Pharmacokinetics.
Kanade R; Boche M; Pokharkar V
AAPS PharmSciTech; 2018 Apr; 19(3):1105-1115. PubMed ID: 29181706
[TBL] [Abstract][Full Text] [Related]
5. Potentiality of raloxifene loaded melittin functionalized lipidic nanovesicles against pancreatic cancer cells.
Fahmy UA; Badr-Eldin SM; Aldawsari HM; Alhakamy NA; Ahmed OAA; Radwan MF; Eid BG; Sayed SRM; El Sherbiny GA; Abualsunun W
Drug Deliv; 2022 Dec; 29(1):1863-1877. PubMed ID: 35708464
[TBL] [Abstract][Full Text] [Related]
6. Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers.
Murthy A; Ravi PR; Kathuria H; Malekar S
Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32486508
[TBL] [Abstract][Full Text] [Related]
7. Poly (ε-caprolactone) nanocapsules for oral delivery of raloxifene: process optimization by hybrid design approach, in vitro and in vivo evaluation.
Aditya N; Ravi PR; Avula US; Vats R
J Microencapsul; 2014; 31(5):508-18. PubMed ID: 24697167
[TBL] [Abstract][Full Text] [Related]
8. Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment.
Aldawsari HM; Ahmed OAA; Alhakamy NA; Neamatallah T; Fahmy UA; Badr-Eldin SM
Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34073780
[TBL] [Abstract][Full Text] [Related]
9. Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability.
Du X; Gao N; Song X
Drug Deliv; 2021 Dec; 28(1):252-260. PubMed ID: 33501870
[TBL] [Abstract][Full Text] [Related]
10. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
11. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
Saini D; Fazil M; Ali MM; Baboota S; Ali J
Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
[TBL] [Abstract][Full Text] [Related]
12. Liposomal formulation for co-delivery of paclitaxel and lapatinib, preparation, characterization and optimization.
Ravar F; Saadat E; Kelishadi PD; Dorkoosh FA
J Liposome Res; 2016 Sep; 26(3):175-87. PubMed ID: 26266828
[TBL] [Abstract][Full Text] [Related]
13. Formulation Design, Statistical Optimization, and In Vitro Evaluation of a Naringenin Nanoemulsion to Enhance Apoptotic Activity in A549 Lung Cancer Cells.
Md S; Alhakamy NA; Aldawsari HM; Husain M; Kotta S; Abdullah ST; A Fahmy U; Alfaleh MA; Asfour HZ
Pharmaceuticals (Basel); 2020 Jul; 13(7):. PubMed ID: 32679917
[TBL] [Abstract][Full Text] [Related]
14. Preparation of liposomal doxorubicin-graphene nanosheet and evaluation of its in vitro anti-cancer effects.
Tajvar S; Mohammadi S; Askari A; Janfaza S; Nikkhah M; Tamjid E; Hosseinkhani S
J Liposome Res; 2019 Jun; 29(2):163-170. PubMed ID: 30235963
[TBL] [Abstract][Full Text] [Related]
15. Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay.
Yurtdaş-Kırımlıoğlu G; Güleç K; Görgülü Ş; Kıyan HT
Microvasc Res; 2022 Jan; 139():104251. PubMed ID: 34520775
[TBL] [Abstract][Full Text] [Related]
16. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal.
Elsheikh MA; Elnaggar YS; Gohar EY; Abdallah OY
Int J Nanomedicine; 2012; 7():3787-802. PubMed ID: 22888234
[TBL] [Abstract][Full Text] [Related]
17. The Optimized Formulation of Tamoxifen-Loaded Niosomes Efficiently Induced Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
Akbarzadeh I; Farid M; Javidfar M; Zabet N; Shokoohian B; Arki MK; Shpichka A; Noorbazargan H; Aghdaei HA; Hossein-Khannazer N; Timashev P; Makvandi P; Vosough M
AAPS PharmSciTech; 2022 Jan; 23(1):57. PubMed ID: 35048234
[TBL] [Abstract][Full Text] [Related]
18. Development of intravaginal rod insert bearing liposomal raloxifene hydrochloride and Leuprolide acetate as a potential carrier for uterine targeting.
Patel A; Dhande R; Thakkar H
J Pharm Pharmacol; 2021 Mar; 73(5):653-663. PubMed ID: 33772288
[TBL] [Abstract][Full Text] [Related]
19. In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance.
Ahmed OA; Badr-Eldin SM
Int J Nanomedicine; 2018; 13():6325-6335. PubMed ID: 30349253
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
Al Asmari AK; Ullah Z; Tariq M; Fatani A
Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
